查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768948

全球食道支架市場

Esophageal Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球食道支架市場規模將達1.227億美元

全球食道支架市場規模預計在2024年為8,910萬美元，預計2030年將達到1.227億美元，2024年至2030年的複合年成長率為5.5%。醫院是本報告分析的細分市場之一，預計其複合年成長率為5.8%，到分析期結束時規模將達到8,150萬美元。專科診所的複合年成長率預計在分析期間為5.1%。

美國市場規模估計為 2,320 萬美元，中國市場預計複合年成長率為 8.4%

美國食道支架市場規模預計在2024年達到2,320萬美元。作為世界第二大經濟體，中國預計在2030年達到2,760萬美元的市場規模，在2024-2030年的分析期內，複合年成長率將達到8.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為3.3%和4.5%。在歐洲，預計德國的複合年成長率為4.0%。

全球食道支架市場－主要趨勢與促進因素摘要

什麼是食道支架？

食道支架是一種置入食道的管狀裝置，用於維持因惡性腫瘤、良性狹窄或其他解剖異常導致食道阻塞患者的管腔通暢性。它們在緩解吞嚥困難等嚴重影響患者生活品質和營養狀況的症狀方面發揮著重要作用。食道支架通常用於治療食道癌（腫瘤阻塞食物通道）或良性病變，例如因長期接觸酸性物質並隨後形成疤痕組織而引起的消化性狹窄。它們也用於治療氣管食道瘺和食道穿孔等併發症，作為更精準治療的過渡手段或提高患者舒適度的安寧療護措施。食道支架由多種材料製成，包括鎳鈦合金（一種可自膨脹的軟性合金）以及覆蓋有矽膠以防止組織浸潤的金屬。這些支架有覆膜支架和無覆膜支架兩種類型。覆膜支架旨在防止腫瘤進展至管腔並控制滲漏，而無覆膜支架則可在良性狹窄的情況下提供更牢固的固定。根據臨床情況，支架置入可在內鏡或螢光透視引導下進行，目的是即時緩解症狀並恢復經口進食。作為一種多功能且微創的解決方案，食道支架已成為治療複雜食道疾病的重要選擇，兼具治癒和緩解的益處。

科技進步如何改善食道支架的功能？

技術進步徹底改變了食道支架的設計和應用，提高了安全性、有效性和患者預後。其中最重要的進展之一是全覆膜自膨式金屬支架 (SEMS) 的引入，它能夠在提供最佳支撐的同時減少腫瘤擴散和食物卡阻等併發症。鎳鈦合金等先進材料的使用，以其超彈性和形狀記憶特性而聞名，使製造商能夠製造出精確貼合食道不規則解剖結構的支架，最大限度地降低移位風險並最大限度地提高患者的舒適度。有些支架配備了防逆流閥，透過預防胃食道逆流（惡性狹窄患者中常見的逆流）來改善術後生活品質。矽膠和聚氨酯等塗層材料的創新也至關重要，它們提供了光滑的內表面，從而減少生物膜形成並防止支架阻塞。此外，將藥物釋放型技術融入食道支架也是近期的突破。這些支架上塗有化療和抗增殖劑，可防止組織增生和狹窄復發，從而延長支架的使用壽命。另一項重大進展是生物分解性支架的開發，這種支架會隨著時間的推移逐漸溶解，使其成為治療不需要移除手術的良性疾病的理想選擇。支架輸送系統的改進也有助於提高支架置入的準確性和安全性。現代輸送系統包括控釋機制、改進的滲透性（以便更好地可視化）和預裝導管導引線等功能，使內視鏡醫師能夠更精確地放置支架，即使在具有挑戰性的解剖結構中也是如此。這些技術進步正在將食道支架轉變為高度複雜的設備，可以治療更廣泛的食道疾病，並減少併發症。

病患人口結構與治療方法的改變如何影響食道支架市場？

由於患者人口結構的變化、食道癌盛行率的上升以及治療模式的轉變，食道支架市場正在迅速發展。全球食道癌，尤其是與胃食道逆流症 (GERD) 和肥胖相關的腺癌的發生率上升，推動了對食道支架等有效安寧療護解決方案的需求。老齡化人口更容易患惡性和良性食道疾病，進一步增加了對長期治療方案的需求，以確保營養攝取並減少吞嚥障礙。這些人口結構的變化促使醫療保健提供者優先考慮提高生活品質的干涉措施，使食道置入術成為無法手術的癌症病例姑息治療的首選方案。同時，治療方法的改變也影響市場。例如，由於併發症風險降低、恢復時間更短以及與內視鏡手術相關的成本更低，內視鏡置入術越來越受到比侵入性更強的外科手術的青睞。這使得它不僅用於治療惡性病例，還用於治療良性狹窄、難治性食道靜脈曲張和術後吻合口漏。此外，以患者為中心的治療模式正在影響產品開發，強調易於插入、患者耐受性良好、術後併發症更少的支架。這種轉變導致支架設計具有更好的固定性、更柔軟的材質以減少潰瘍形成，以及創新的防移位功能以確保最佳定位。新興市場擴大採用微創支架置入術，這也推動了成長，因為這些地區對醫療保健的投資不斷增加，並且對食道疾病先進治療方案的認知不斷提高。

推動食道支架市場成長的關鍵因素有哪些？

食道支架市場的成長受到多種關鍵因素的推動，包括食道癌盛行率的上升、支架技術的進步以及微創治療的日益普及。吸煙、大量飲酒和慢性胃酸倒流等生活習慣會增加食道癌的發生率，尤其是在已開發國家。這導致對安寧療護的需求增加，以緩解吞嚥障礙並提高晚期癌症患者的生活品質。諸如開發具有增強的靈活性和抗遷移性能的自膨式金屬支架等技術創新也在擴大食道支架的臨床應用方面發揮了關鍵作用。藥物釋放型和生物分解性支架的加入為治療良性疾病和預防血管再阻塞提供了新的治療選擇，進一步刺激了市場需求。另一個主要成長要素是內視鏡手術的廣泛應用，這種手術比傳統手術侵入性更小，恢復時間更快。隨著越來越多的醫療機構將內視鏡支架置入置入術作為治療良惡性食道阻塞的標準方法，先進支架的需求也隨之飆升。此外，醫療基礎設施的不斷擴張、醫療支出的不斷成長以及新興市場食道疾病的盛行率不斷上升，也為市場成長創造了新的機會。價值導向型醫療保健的趨勢也推動了人們對支架的興趣，因為支架能夠改善長期療效、降低併發症發生率，為食道疾病的治療提供經濟高效的解決方案。這些市場促進因素正在改變食道支架市場，隨著全球醫療體系持續優先考慮食道疾病的微創解決方案，預計該市場將持續擴張。

部分

最終使用者（醫院、專科診所、門診手術中心）

受訪公司範例

  • Andratec GmbH
  • Boston Scientific Corporation
  • BVM Medical Limited
  • CR Bard, Inc.
  • Cook Group Incorporated
  • Ella-CS, sro
  • Endo-Flex GmbH
  • MITech
  • Merit Medical Systems, Inc.
  • Taewoong Medical Co., Ltd.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP17707

Global Esophageal Stents Market to Reach US$122.7 Million by 2030

The global market for Esophageal Stents estimated at US$89.1 Million in the year 2024, is expected to reach US$122.7 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$81.5 Million by the end of the analysis period. Growth in the Specialty Clinics segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$23.2 Million While China is Forecast to Grow at 8.4% CAGR

The Esophageal Stents market in the U.S. is estimated at US$23.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Esophageal Stents Market - Key Trends and Drivers Summarized

What Are Esophageal Stents and Why Are They Used?

Esophageal stents are tubular devices inserted into the esophagus to maintain luminal patency in patients suffering from esophageal obstructions caused by malignant tumors, benign strictures, or other anatomical abnormalities. They play a critical role in alleviating symptoms like dysphagia (difficulty swallowing), which can severely impact a patient’s quality of life and nutritional status. Esophageal stents are typically used in cases of esophageal cancer, where the tumor obstructs the passage of food, or in benign conditions such as peptic strictures, which result from prolonged acid exposure and subsequent scar tissue formation. They can also be utilized to manage complications like tracheoesophageal fistulas or esophageal perforations, serving as a bridge to more definitive treatment or as a palliative measure to enhance the patient’s comfort. Esophageal stents are made from various materials such as nitinol, a flexible alloy that allows for self-expansion, or silicone-covered metal, which helps prevent tissue ingrowth. These stents come in both covered and uncovered variants: covered stents are designed to block tumor growth into the lumen and manage leaks, while uncovered stents provide a firmer anchorage in cases of benign strictures. Depending on the clinical scenario, stent placement can be performed endoscopically or under fluoroscopic guidance, with the aim of immediate symptomatic relief and the restoration of oral intake. As a versatile and minimally invasive solution, esophageal stents have become an essential option in managing complex esophageal conditions, offering both therapeutic and palliative benefits.

How Are Technological Advancements Improving the Functionality of Esophageal Stents?

Technological advancements have revolutionized the design and application of esophageal stents, enhancing their safety, effectiveness, and overall patient outcomes. One of the most significant developments is the introduction of fully covered self-expanding metal stents (SEMS), which provide optimal support while reducing complications such as tumor ingrowth and food impaction. The use of advanced materials like nitinol, known for its superelasticity and shape memory properties, has allowed manufacturers to create stents that conform precisely to the irregular anatomy of the esophagus, minimizing the risk of migration and maximizing patient comfort. Some stents now feature anti-reflux valves, which prevent gastroesophageal reflux-a common issue in patients with malignant strictures-thus improving their quality of life post-procedure. Innovations in coating materials, such as silicone or polyurethane, have also been pivotal, providing a smooth inner surface that reduces biofilm formation and prevents stent obstruction. Moreover, the integration of drug-eluting technology into esophageal stents is a recent breakthrough. These stents are coated with chemotherapeutic agents or anti-proliferative drugs to prevent tissue hyperplasia and recurrent stricture formation, extending the functional lifespan of the stent. Another key advancement is the development of biodegradable stents, which gradually dissolve over time, making them ideal for treating benign conditions without the need for removal procedures. Improvements in stent delivery systems have also contributed to the increased precision and safety of stent placement. Modern delivery systems are equipped with features such as controlled release mechanisms, enhanced radiopacity for better visualization, and preloaded guidewires, enabling endoscopists to deploy stents more accurately even in challenging anatomies. These technological strides are transforming esophageal stents into highly sophisticated devices that address a broader range of esophageal disorders with fewer complications.

How Are Shifting Patient Demographics and Treatment Approaches Impacting the Esophageal Stent Market?

The esophageal stent market is evolving rapidly, driven by changes in patient demographics, rising prevalence of esophageal cancers, and shifts in treatment paradigms. The global increase in esophageal cancer cases, especially adenocarcinoma linked to gastroesophageal reflux disease (GERD) and obesity, has led to a heightened demand for effective palliative solutions like esophageal stents. An aging population, which is more susceptible to both malignant and benign esophageal conditions, has further fueled the need for long-term management options that can ensure nutritional intake and reduce dysphagia. This demographic shift has prompted healthcare providers to prioritize interventions that enhance the quality of life, making esophageal stenting a preferred choice for palliative care in inoperable cancer cases. Simultaneously, changes in treatment approaches are also influencing the market. For instance, there is an increasing preference for endoscopic stenting over more invasive surgical procedures due to the reduced risk of complications, shorter recovery times, and lower costs associated with endoscopic techniques. This has expanded the use of esophageal stents in not only malignant cases but also in treating benign strictures, refractory esophageal varices, and postoperative anastomotic leaks. Moreover, patient-centric care models are shaping product development, with a growing emphasis on stents that offer ease of insertion, better patient tolerance, and minimal post-procedure complications. This shift has led to the design of stents with improved anchorage, softer materials to reduce ulceration, and innovative anti-migration features that ensure optimal positioning. The increasing adoption of minimally invasive stenting procedures in emerging markets is also driving growth, as these regions experience rising healthcare investment and a growing awareness of advanced treatment options for esophageal conditions.

What Are the Key Growth Drivers in the Esophageal Stent Market?

The growth in the esophageal stent market is driven by several critical factors, including the rising incidence of esophageal cancer, advancements in stent technology, and the increasing adoption of minimally invasive treatments. One of the primary drivers is the global surge in esophageal cancer cases, particularly in developed countries, where lifestyle factors such as smoking, heavy alcohol use, and chronic acid reflux have contributed to a higher incidence of adenocarcinoma. This has led to an increased need for palliative care options that can alleviate dysphagia and enhance the quality of life for patients in advanced stages of cancer. Technological innovations, such as the development of self-expanding metal stents with enhanced flexibility and anti-migration properties, are also playing a pivotal role in expanding the clinical applications of esophageal stents. The incorporation of drug-eluting and biodegradable stents is providing new therapeutic options for managing benign conditions and preventing restenosis, further boosting market demand. Another significant growth driver is the widespread adoption of endoscopic procedures, which are less invasive than traditional surgery and associated with faster recovery times. As more healthcare providers embrace endoscopic stenting as the standard approach for treating both malignant and benign esophageal obstructions, the demand for advanced stents has surged. Furthermore, the expansion of healthcare infrastructure in emerging markets, along with increased healthcare expenditure and the rising prevalence of esophageal disorders, is creating new opportunities for market growth. The trend toward value-based healthcare is also driving interest in stents that offer improved long-term outcomes and reduced complication rates, making them a cost-effective solution in the management of esophageal diseases. These diverse growth drivers are transforming the esophageal stent market, positioning it for sustained expansion as healthcare systems worldwide continue to prioritize minimally invasive solutions for esophageal pathologies.

SCOPE OF STUDY:

The report analyzes the Esophageal Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Andratec GmbH
  • Boston Scientific Corporation
  • BVM Medical Limited
  • C. R. Bard, Inc.
  • Cook Group Incorporated
  • Ella - CS, s.r.o.
  • Endo-Flex GmbH
  • M.I.Tech
  • Merit Medical Systems, Inc.
  • Taewoong Medical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Esophageal Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Esophageal Cancers Throws the Spotlight on Stenting as a Palliative Solution
    • Growing Adoption of Minimally Invasive Treatments Propels Demand for Esophageal Stents
    • Here's How Technological Advancements in Stent Design Strengthen the Business Case for Adoption
    • Expanding Use of Self-Expanding Metal Stents Drives Market Growth with Enhanced Clinical Outcomes
    • Increasing Preference for Endoscopic Procedures Generates Demand for Esophageal Stenting
    • Here's the Story: Rising Geriatric Population Sustains Growth in Demand for Dysphagia Management
    • Innovations in Anti-Migration and Anti-Reflux Features Expand the Addressable Market
    • Growing Incidence of Esophageal Strictures Spurs Demand for Safe and Effective Stent Solutions
    • Trend Toward Bioabsorbable Stents Expands Market Opportunity in Short-Term Therapeutic Applications
    • Here's How Increasing Use in Benign Conditions Generates New Market Opportunities
    • Rising Incidence of Gastroesophageal Reflux Disease (GERD) Creates Niche Growth Potential
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Esophageal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Esophageal Stents Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Esophageal Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Esophageal Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Esophageal Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Esophageal Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Esophageal Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Esophageal Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Esophageal Stents by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Esophageal Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION